Jennifer R Rider

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study
    Jennifer R Rider
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Eur Urol 63:88-96. 2013
  2. pmc Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
    Andreas Pettersson
    Affiliations of authors Department of Epidemiology AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM and Department of Nutrition MJS, ELG, Harvard School of Public Health, Boston, MA Channing Division of Network Medicine AP, KLP, JRR, MJS, ELG, LAM and Division of Preventive Medicine HDS, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA Department of Pathology, Brigham and Women s Hospital, Boston, MA RTL, ECS, ML Center for Molecular Oncologic Pathology RTL, RF, ECS, MF, SF, NEM, ML, Department of Radiation Oncology NEM, Centre for Regenerative Medicine
    J Natl Cancer Inst 105:1881-90. 2013
  3. pmc Gleason grade progression is uncommon
    Kathryn L Penney
    Department of Epidemiology, Harvard School of Public Health, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Res 73:5163-8. 2013
  4. pmc A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer
    Jonathan D Schoenfeld
    Harvard Radiation Oncology Program, Boston, Massachusetts, USA
    Clin Cancer Res 19:1612-9. 2013
  5. pmc Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Causes Control 23:1359-66. 2012
  6. pmc Temporal trends in cause of death among Swedish and US men with prostate cancer
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, 9th Floor, Boston, MA 02115, USA
    J Natl Cancer Inst 104:1335-42. 2012
  7. pmc The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis
    Andreas Pettersson
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 21:1497-509. 2012
  8. pmc Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study
    Kathryn M Wilson
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 103:876-84. 2011
  9. pmc Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer
    Preet K Dhillon
    Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 20:2618-27. 2011

Detail Information

Publications9

  1. doi request reprint Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study
    Jennifer R Rider
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Eur Urol 63:88-96. 2013
    ..Limited data exist on long-term outcomes among men with prostate cancer (PCa) from population-based cohorts incorporating information on clinical risk category...
  2. pmc Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
    Andreas Pettersson
    Affiliations of authors Department of Epidemiology AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM and Department of Nutrition MJS, ELG, Harvard School of Public Health, Boston, MA Channing Division of Network Medicine AP, KLP, JRR, MJS, ELG, LAM and Division of Preventive Medicine HDS, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA Department of Pathology, Brigham and Women s Hospital, Boston, MA RTL, ECS, ML Center for Molecular Oncologic Pathology RTL, RF, ECS, MF, SF, NEM, ML, Department of Radiation Oncology NEM, Centre for Regenerative Medicine
    J Natl Cancer Inst 105:1881-90. 2013
    ..TMPRSS2:ERG is a hormonally regulated gene fusion present in about half of prostate tumors. We investigated whether obesity, which deregulates several hormonal pathways, interacts with TMPRSS2:ERG to impact prostate cancer outcomes...
  3. pmc Gleason grade progression is uncommon
    Kathryn L Penney
    Department of Epidemiology, Harvard School of Public Health, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Res 73:5163-8. 2013
    ..This has implications for the understanding of tumor progression and prognosis, and may help patients diagnosed with lower grade disease feel more comfortable choosing active surveillance...
  4. pmc A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer
    Jonathan D Schoenfeld
    Harvard Radiation Oncology Program, Boston, Massachusetts, USA
    Clin Cancer Res 19:1612-9. 2013
    ..To study associations between single nucleotide polymorphisms (SNP) in Ribonuclease L (RNASEL), a gene implicated in inflammation and prostate cancer risk, and outcomes after radiation therapy...
  5. pmc Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Causes Control 23:1359-66. 2012
    ..As serum vitamin D levels vary by season, we sought to determine whether the expression of genes on the vitamin D pathway, assessed in prostate tumor tissue, do the same...
  6. pmc Temporal trends in cause of death among Swedish and US men with prostate cancer
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, 9th Floor, Boston, MA 02115, USA
    J Natl Cancer Inst 104:1335-42. 2012
    ..Temporal trends in specific causes of death among prostate cancer patients have not been well described...
  7. pmc The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis
    Andreas Pettersson
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 21:1497-509. 2012
    ..Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):v-ets erythroblastosis virus E26 oncogene homolog (ERG) has prognostic value in prostate cancer is unclear...
  8. pmc Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study
    Kathryn M Wilson
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 103:876-84. 2011
    ..Because of these biological activities, coffee may be associated with a reduced risk of prostate cancer...
  9. pmc Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer
    Preet K Dhillon
    Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 20:2618-27. 2011
    ..However, the role of genetic variation in the adiponectin (ADIPOQ) and receptor genes (ADIPOR1/R2) in prostate cancer is largely unknown...